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& Abstract
Background: To fully understand the burden of painful
diabetic neuropathy (PDN), we investigated the relationship
of pain catastrophizing with disability and quality of life in
patients with PDN. Furthermore, we studied the mediating
roles of physical activity and/or decline in physical activity.
Methods: This questionnaire-based cross-sectional study
included 154 patients with PDN. Linear regression analyses,
adjusted for age, gender, pain intensity, and insulin treat-
ment, were performed to assess the association of pain
catastrophizing (Pain Catastrophizing Scale [PCS]) with the
outcome variables disability (Pain Disability Index [PDI]) and
quality of life (Norfolk Quality of Life Questionnaire Diabetic
Neuropathy Version [QOL-DN]). Themediating roles of actual
physical activity (Physical Activity Rating Scale [PARS]) and
perceived Physical Activity Decline (PAD) were assessed using
mediation analyses according to Baron and Kenny.
Results: This study included 154 patients (62% male). Mean
age was 65.7 years (SD = 6.6). PCS (M = 20.3, SD = 13.1) was
significantlyassociatedwithPDI (M = 32.4, SD=17.0;R2 = 0.356,
P < 0.001), QOL-DN (M = 52.6, SD = 26.1; R2 = 0.437, P < 0.001),
and PAD (M = 7.4, SD = 5.7; R2 = 0.087, P = 0.045). PAD acted as
a partial mediator in the associations of PCS with PDI and QOL-
DN, respectively. There was no association of PCS with PARS.
Conclusions: Pain catastrophizing was associated with
increased disability and decreased quality of life in patients
with PDN. Also, it was associated with a perceived decline in
physical activity, which had a mediating role in the associa-
tion between catastrophizing and disability and quality of
life, respectively. This study emphasizes the role of catas-
trophic thinking about pain and the experienced loss in daily
activities due to PDN. &
Key Words: painful diabetic neuropathy, chronic pain,
neuralgia, diabetic, psychology, polyneuropathy
INTRODUCTION
Up to 20-60% of patients with diabetes mellitus develop
painful diabetic neuropathy (PDN).1 PDN is known to
have a negative impact on physical and mental quality of
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life (QOL) and is associated with socioeconomic conse-
quences including loss of work time.2 Sensory and motor
deficits in patients with PDN can lead to less engagement
in physical activity, which, in turn, can further impair
psychosocial well-being.3,4 Research has shown that
patients with PDN often suffer from enhanced levels of
anxiety, fears, and depression.5
The interpretation of pain and its consequences on
daily life are influenced by behavioral and cognitive
efforts used in the attempt of dealing with pain. An
example of a coping strategy that has received much
attention in studies with patients with various chronic
pain syndromes is pain catastrophizing.6–10 Pain catas-
trophizing is defined as a negative cognitive set brought to
bear during actual or anticipated pain experience, as it
refers to the process during which pain is interpreted as
being extremely threatening.8 It has been suggested that
as a function of negative experiences involving pain,
catastrophic thinking may lead to the development of a
coping style that leads patients to be excessively vigilant
to pain-related stimuli, to focus excessively on pain
sensations, and to expect that aversive stimuli will result
in experiences of heightened pain.11 Pain catastrophiz-
ing, as measured with the Pain Catastrophizing Scale
(PCS)12, has been associated with heightened pain experi-
ence in patients with different types of neuropathic pain
such as postherpetic neuralgia6, phantom limb pain,7 and
pain associated with spinal cord injury.10 It has also shown
to have a negative impact on the level of disability,
depression, and anxiety and increase consumption of
analgesic medication and pain-related behavior.10,11,13
An association of pain catastrophizing with decreased
physical activity hasbeen found ingroupsofpatientswith
whiplash and soft-tissue injuries.14 The association of
pain catastrophizing with physical activity, QOL, and
perceived disability in patientswith PDNhas not yet been
fullyelucidated. It isplausiblethatcatastrophicthinkingis
also associated with a lower level of physical activity and
more perceived disability in patients with PDN. The
question arises whether catastrophic thinking leads to an
experienced decline in physical activity as compared to
patients’ habitual activity level, orwhether it is associated
with theactual level ofphysical activity. Furthermore, it is
unknown whether the level of physical activity affects
perceived disability and/or QOL in patients with PDN.
The aim of this study, therefore, was to further unravel the
underlying mechanisms linking pain catastrophizing to
(perceived)physicalactivity,disability,andQOLinpatients
with PDN. We hypothesized that pain catastrophizing is
associated with perceived disability and decreased QOL in
patientswith PDNand that these associations aremediated
bytheexperienceddeclineinphysicalactivityratherthanthe
actual level of physical activity.
METHODS
Patients
In this study, 154 patients with type 2 diabetes mellitus,
aged > 18 years who suffered from peripheral polyneu-
ropathy,wereincluded.Eligibility forthisstudywasbased
on the following: providing written informed consent,
having type 2 diabetes mellitus, aged > 18 years, and
suffering from peripheral polyneuropathy. Additionally,
the Diabetic Neuropathy Symptom Score (DNS)15 was
used to diagnose diabetic neuropathy. This scale consists
of 4 items: (1) unsteadiness in walking; (2) pain; (3)
burning or aching at legs or feet, prickling sensations in
legs or feet; and (4) numbness in legs or feet.15 The DNS
has been validated for diabetic polyneuropathy and has
shown to have a high sensitivity and specificity.15
Neuropathic pain in the feet was assessed using the
interview section of the Douleur Neuropathique 4
Questions(DN4-interview),whichconsistsof seven items
relating to the pain description (burning, painful cold,
electric shocks) and to its abnormal sensations (tingling,
pins and needles, numbness, itching).16 DN4 and DN4-
interview scores showed a high diagnostic accuracy for
painful diabetic polyneuropathy.16 Patients with a DNS
score ≥1 and neuropathic pain in the feet (DN4 ≥ 4) for at
least 3 months and being clinically stable were included.
Patientswere excluded if therewere other conditions that
could lead to pain in the feet and/or damage to the
peripheral nervous system and if they were not able to
understand the Dutch language.
Procedure
Letters of interest were sent to patients derived from a
database of patients with type 2 diabetes from a regional
hospital in the south of the Netherlands (VieCuri, Venlo,
the Netherlands). In total, a number of 2142 letters of
interest were sent to patients randomly selected from the
database. A total of 388 letters of interest were returned,
of which 237 (61%) patients indicated that they were
willing to participate in the study. Of the 151 patients
who declined to participate, 94 patients reported the
reason: no neuropathic pain (n = 54), type I DM
(n = 23), death (n = 9), personal circumstances
(n = 4), moved to a different address (n = 2), phantom
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limb pain (n = 1), no DM (n = 1). Of the 237 patients
who received a questionnaire, 183 actually filled in and
returned the questionnaire (47% of 388 patients that
returned the letter of interest). Inclusion criteria were
independently checked by a research assistant and a
physician in rehabilitation medicine. Of the 183
patients, 154 met the criteria for inclusion. Informed
consent was obtained from all subjects; the experimental
protocol was approved by the Medical Ethics Commit-
tee of Maastricht University, the Netherlands. The
procedure of inclusion is shown in Figure 1.
Measures
All data were retrieved by self-report questionnaires.
Patient characteristics included sociodemographic fac-
tors and pain-related measures. Behavioral factors were
measured using various questionnaires, as is described in
the following paragraphs.
Patient Characteristics. The following factors were
assessed: age (years), gender, nationality, and having
insulin treatment for DM (yes/no).
Pain and Pain Catastrophizing. Durationofcomplaints
of neuropathic pain was assessed (months). In addition,
pain intensity was measured using a visual analog scale
(VAS), ranging from 0 to 10. Pain catastrophizing was
measuredusingtheDutchversionof thevalidated13-item
PCS. This questionnaire measures negative thoughts and
beliefs during actual or anticipated painful experiences.
The itemsare scoredona5-pointLikert scalewith scoring
possibilities ranging from “not at all” (score = 0) to
“always” (score = 4). The PCS total score is computed by
summingresponses toall13 itemsandranges from0to52.
High scores indicate that more catastrophic thoughts or
feelings are experienced. Psychometric properties of the
PCSappearedadequate inprevious research: It correlated
highly (r = 0.73) with the catastrophizing subscale of the
DutchPainCognitionList (PCL)andhadagoodtemporal
stability (Pearson’s r2 = 0.92).17 The PCS has shown to
have adequate to excellent internal consistency.18
Disability. Perceived disability was measured using the
Pain Disability Index (PDI). This 7-item questionnaire
investigates the magnitude of the self-reported disability
indifferent situations suchaswork, leisure time, activities
ofdaily living (ADLs), and sports.Each item is scoredona
numeric rating scale ranging from 0 (no perceived
disability) to 10 (maximum perceived disability). Scores
of the individual itemswere added up to provide the total
score. PDIhas showntobe internally reliable (Cronbach’s
alpha = 0.86) and significantly correlated with objective
indices of disability such as time spent in bed, psychoso-
maticsymptoms,stoppingactivitiesbecauseofpain,work
status, pain duration, usual pain intensity, QOL, pain
extent, and education (r = 0.74).19
Quality of Life. Quality of life was measured using the
47-itemNorfolk Quality of Life Questionnaire, Diabetic
Neuropathy Version, QOL-DN20, a self-administered
questionnaire designed to capture and quantify the
perceived impact of diabetic neuropathy on the QOL,
physical, and psychosocial functioning of patients with
2142 Letters of interest sent
388 Letters of interest filled in and returned
237 interested participants 
who received the questionnaire 
183 filled in and returned the questionnaire
151 resigned
- 54 no neuropathic pain 
- 23 type I DM 
- 9 death 
- 4 personal circumstances 
- 2 moved to a different address 
- 1 phantom limb pain 
- 1 no DM 
- 57 unknown
154 met inclusion criteria; 
age > 18, DNS ≥ 1 and DN4 ≥ 4, complaints > 3 monthsFigure 1. Flowchart of inclusion
procedure.
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diabetic neuropathy. Fourteen of the items are of a
health-related, biographical nature and are not scored.
Therefore, they were excluded from this study. Items
1–7 (Part I) are an inventory of symptoms of neuropathy
in the feet, legs, arms, and hands, respectively. For each
body part separately, the presence of a symptom is
scored as 1 and absence of a symptom is scored as 0. The
absence of the symptom in all body parts is checked as
“none.” Items 8-35 (Part II) concern ADLs and are
scaled on a 5-point Likert scale ranging from 0 (“not a
problem”) to 4 (“severe problem”). The 35 scored
questions comprise the entire scale and can be grouped
according to small fiber, large fiber, and autonomic
nerve function symptoms and ADLs. Intraclass correla-
tion coefficients have shown to be > 0.9 for most
domains.20 Internal consistency of the fiber-specific
domains using Cronbach’s alpha was considered > 0.6
and up to 0.8.20 Scores in individual domains (Parts I
and II) were aggregated to provide a total score.
Physical Activity and Perceived Activity Decline. The
level of activity was determined using two concepts:
physical activity and perceived activity decline (PAD).
Physical activitywasmeasuredusing thePhysicalActivity
Rating Scale (PARS)21, which consists of 20 daily activ-
ities. On a 5-point Likert scale (range 0–4), patients score
how often they have performed these activities in the past
2 weeks.Toestimate thepain-relateddecline inactivities,
the PAD question was added to the PARS. For each
activity, patients were asked to indicate how frequently
they had performed the specified activity in the last
2 weeks using the following response categories: never,
rarely, now and then, often, and very often. Furthermore,
patients indicated whether they would have performed
this specific activity more often if they would not have
pain. If the answerwas yes for a specific item, 1 point was
counted. On the contrary, if the answer was no, the score
on that item was 0. The total sum score for 20 activities
resulted in a score for PAD; a perceived decline in the
level of physical activity after the onset of pain as
perceived by the patient, with a theoretical range in PAD
of 0–20. The internal consistency (Cronbach’s alpha
= 0.92) and reliability (ICC = 0.93) of PAD have shown
to be good.22
Statistical Analyses
Data were analyzed using the Statistical Package for
Social Sciences for Windows, version 22.0 (SPSS Inc.,
Chicago, IL, USA). Results for groups (baseline charac-
teristics) were expressed as a mean score and standard
deviation. Comparisons between two groups were
performed using Student’s t-test for independent sam-
ples. To assess the association of pain catastrophizing
(PCS) with perceived disability (PDI) and decreased
QOL (QOL-DN), linear regression analyses were per-
formed with PDI and QOL-DN as independent vari-
ables, adjusted for the study covariates pain intensity,
age, gender, and insulin treatment (independent vari-
ables).
To evaluate the mediating role of PARS and PAD in
the association of pain catastrophizing and perceived
disability or QOL, multiple linear regression analyses
were performed according to Baron and Kenny.23 To
illustrate this procedure, the analyses for the mediation
of PAD in the association of PCS and PDI are
described. In the first analysis, PDI was introduced
as the dependent variable and PCS, pain intensity, age,
gender, and insulin treatment as independent variables
(step 1). In the second analysis, PAD was introduced
as dependent variable, with the same independent
variables as in the first analysis (step 2). The third
analysis resemble the first (PDI-dependent variable)
with the addition that PAD is added to the earlier set
of independent variables (step 3). If PAD acts as
mediator in the relation of pain catastrophizing and
PDI, the contribution of PCS should be statistically
significant in the first and second analyses, whereas the
effect should be attenuated in the third analysis after
introduction of PAD. To evaluate the mediating role
of PARS in the association with PCS and PDI, and the
mediating role of both PARS and PAD in the associ-
ation with PCS and QOL-DN, three identical proce-
dures were performed.
For all multiple linear regression analyses, standard-
ized beta coefficients and their significance were tested
under the null hypothesis that the coefficient differed
from 0. To control for multicollinearity, variable infla-
tion factors (VIFs) were checked and should all be below
three. Data were checked for normality and missing
values. Mean imputation was performed to account for
missing data in total scores.
RESULTS
Baseline Characteristics And Pain-Related Outcomes
This study included 96 male and 58 female patients with
a mean age of 65.7 years (SD = 6.6) (Table 1). Mean
duration of complaints of PDN was 72.3 months (SD =
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57.6), and 65% of the participants were on insulin
treatment. Pain-related variables: mean pain intensity
score was 4.8 (SD = 2.0), mean PCS score was 20.3 (SD
= 13.1), mean PDI score was 32.4 (SD = 17.0), and mean
QOL-DN score was 52.6 (SD = 26.1). Activity-related
variables: Mean PARS score was 45.3 (SD = 9.0), and
mean PAD score was 7.4 (SD = 5.7). There were no
differences between men and women on the baseline
characteristics or pain-related outcomes (P > 0.05 for
all variables, Table 1).
Step 1: The Association Between Pain Catastrophizing
and Perceived Disability, and QOL, Respectively
PCS significantly contributed to the association with
PDI (b = 0.311, P < 0.001) (Table 2). Furthermore,
insulin treatment (b = 0.151, P = 0.028) and pain
intensity (b = 0.375, P < 0.001) significantly con-
tributed to the association with pain catastrophizing
and perceived disability.
PCS was significantly associated with QOL-DN
(b = 0.373, P < 0.001) (Table 3), indicating a lower
QOL in patients who engage in catastrophic thinking.
Also, insulin treatment and pain intensity significantly
contributed to the association of pain catastrophizing
and quality of life (b = 0.140, P = 0.042 and b = 0.388,
P < 0.001, respectively).
Step 2: The Association Between Pain Catastrophizing
and Perceived Activity Decline, and Physical Activity,
Respectively
PCS was significantly associated with PAD (b = 0.182,
P = 0.045),whereas the level of pain intensity showed no
contribution to this association (b = 0.151, P = 0.095)
(Table 4). There was no statistically significant associa-
tion of PCS with PARS, indicating that pain catastro-
phizing seems to be associatedwith a perceived decline in
physical activity rather than with the actual level of
physical activity. Only pain intensity showed a statisti-
cally significant contribution to the association with pain
catastrophizing and physical activity (b = -0.215,
P = 0.015) (Table 4).
Step 3A: Mediation Analyses of PAD in the Association
of Pain Catastrophizing with Perceived Disability
The first and second steps of the mediation analyses are
described above. The mediating role of PAD was
analyzed in the association of pain catastrophizing and
perceived disability. No analyses were performed to
investigate the mediating role of PARS, as the obligatory
association of PARS with PCS was absent.
The full mediation analysis is shown in Table 2.
When introduced as an independent variable, PAD
showed to significantly contribute to the association of
PCS with PDI (b = 0.401, P < 0.001). The effects of
pain catastrophizing, insulin treatment, and pain inten-
sity were all attenuated (b = 0.226, P = 0.001;
b = 0.106, P < 0.001; and b = 0.307, P = 0.100,
respectively), indicating that Physical Activity Decline
acted as a partial mediator in the association between
Table 1. Baseline Characteristics
N Mean/n SD/%
Demographic
variables
Age 154 65.7  6.6
Gender (Male/Female) 154 96/58 62%/38%
Insulin treatment 154 100 65%
Pain-related
measures
Duration of complaints 144 72.3  57.6
Pain intensity 153 4.8  2.0
PCS 151 20.3  13.1
Consequences
in daily life
QOL-DN 131 52.6  26.1
PDI 150 32.4  17.0
PARS 152 45.3  9.0
PAD 141 7.4  5.7
Data are presented as mean  SD or n (%), as appropriate. Age (years), duration of
complaints (months), pain intensity (VAS 0-10), PCS, Pain Catastrophizing Scale; QOL,
Quality of Life; PDI, Pain Disability Index; PARS, Physical Activity Rating Scale; PAD,
Perceived Activity Decline.
Table 2. Mediation analyses for Pain Catastrophizing,
Perceived Disability, and Physical Activity Decline
Dependent
variable
Independent
variable R2
Adjusted
R2
Standar-
dized b P-value
1 PDI PCS 0.356 0.333 0.311 0.000
Age 0.018 0.791
Gender 0.078 0.256
Insulin
treatment
0.151 0.028
Pain
intensity
0.375 0.000
2 PAD PCS 0.087 0.052 0.182 0.045
Age 0.053 0.522
Gender 0.031 0.711
Insulin
treatment
0.074 0.374
Pain
intensity
0.151 0.095
3 PDI PCS 0.482 0.457 0.226 0.001
Age 0.041 0.518
Gender 0.082 0.199
Insulin
treatment
0.106 0.100
Pain
intensity
0.307 0.000
PAD 0.401 0.000
Analyses in three steps to assessmediating role of PAD in the association of PCS and PDI.
PDI, Pain Disability Index; PCS, Pain Catastrophizing Scale; PAD, Perceived Activity
Decline.
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pain catastrophizing and perceived disability. VIFs were
checked and were all below 3.
Step 3B: Mediation Analyses of PAD in the Association
of Pain Catastrophizing with QOL
To assess whether the association of pain catastrophiz-
ing and QOL is mediated by Physical Activity Decline,
the same set of analyses were performed. PAD showed
to significantly contribute to the association with PCS
and QOL-DN (b = 0.336, P < 0.001) (Table 3). The
effects of pain catastrophizing, insulin treatment, and
pain intensity were again all attenuated after the
introduction of PAD (b = 0.319, P < 0.001;
b = 0.091, P = 0.162; and b = 0.343, P < 0.001,
respectively). This analysis shows that Physical Activity
Decline also acted as a partial mediator in the associ-
ation of pain catastrophizing and QOL. VIFs were
checked and were all below three.
DISCUSSION
Pain catastrophizing is characterized by a tendency to
magnify the threat value of pain stimuli, to feel helpless
in the context of pain, and by a relative inability to
inhibit pain-related thoughts in anticipation of, during,
or following a painful encounter. Mean PCS scores in
this sample of Dutch patients suffering from PDN were
comparable to scores of patients with other pain
syndromes.6,8,24 We found that pain catastrophizing
was associated with increased perceived disability and
decreased QOL in patients with PDN. Interestingly,
pain catastrophizing was associated with the subjective
feeling of loss of physical activities due to pain
(perceived Physical Activity Decline), but not the self-
reported estimate of one’s actual level of activity. Our
findings suggest that patients with PDN who catastro-
phize about their pain experience a greater burden of
PDN due to their perceived, but not actual, decline in
physical activity.
In the biopsychosocial perspective, pain is considered
to be of a complex and multifactorial origin, taking into
account biological, psychological, and social factors,
resulting in individual differences in motoric, cognitive,
and psychophysiological responses.25 One model within
this perspective is the fear-avoidance model, which
addresses the way a patient interprets their pain. If pain
is interpreted as nonthreatening, patients are likely to
stay engaged in daily activities. If, however, patients
misinterpret pain as being threatening, a vicious cycle of
catastrophic thinking may be initiated leading to exces-
sive fear of pain/injury, resulting in avoidance of
physical activities, disuse, depression, and disabil-
ity.26,27 The fear-avoidance model has been extensively
studied in patients with chronic low back pain28, but
only limited information is available about the way
patients with PDN interpret their pain. In line with the
fear-avoidance model, this study shows that pain catas-
Table 3. Mediation analyses for Pain Catastrophizing,
QOL, and Physical Activity Decline
Dependent
variable
Independent
variable R2
Adjusted
R2
Standar-
dized b P-value
1 QOL-DN PCS 0.437 0.414 0.373 0.000
Age 0.023 0.738
Gender 0.047 0.497
Insulin
treatment
0.140 0.042
Pain
intensity
0.388 0.000
2 PAD PCS 0.087 0.052 0.182 0.045
Age 0.053 0.522
Gender 0.031 0.711
Insulin
treatment
0.074 0.374
Pain
intensity
0.151 0.095
3 QOL-DN PCS 0.529 0.504 0.319 0.000
Age 0.012 0.851
Gender 0.046 0.483
Insulin
treatment
0.091 0.162
Pain
intensity
0.343 0.000
PAD 0.336 0.000
Analyses in three steps to assess mediating role of PAD in the association of PCS and
QOL-DN. QOL-DN, Norfolk Quality of Life Questionnaire -Diabetic Neuropathy Version;
PCS, Pain Catastrophizing Scale; PAD, Perceived Activity Decline.
Table 4. Association of Pain Catastrophizing and Physical
Activity, and Physical Activity Decline respectively
Dependent
Variable
Independent
Variable R2
Adjusted
R2
Standar-
dized b P-value
PAD PCS 0.087 0.052 0.182 0.045
Age 0.053 0.522
Gender 0.031 0.711
Insulin
treatment
0.074 0.374
Pain
intensity
0.151 0.095
PARS PCS 0.097 0.066 0.131 0.137
Age 0.048 0.548
Gender 0.008 0.325
Insulin
treatment
0.008 0.317
Pain
intensity
0.215 0.015
Linear regression analyses of PCS and PARS, and PAD, respectively. PAD, Perceived
Activity Decline; PARS, Physical Activity Rating Scale; PCS, Pain Catastrophizing Scale.
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trophizing can induce the feeling of not being able to be
physically active rather than affecting the actual level of
physical activity and that this feeling results in perceived
disability and a lower QOL in patients with PDN. These
results suggest that it is important to address these
subjective measures of perceived disability when assess-
ing the effects of chronic pain syndromes on daily life
activities and QOL.
It is known that PDN itself has a negative effect on
QOL.1 Our results indicate that catastrophic thinking
may play a role in this association. Mean QOL-DN
score (52.6) was comparable to other studies in patients
with PDN29. Studies in patients with various pain
conditions have shown that pain catastrophizing nega-
tively influenced depression and anxiety.10,4 Further-
more, pain catastrophizing has been associated with
increased pain-related disability and behavior.8,30 The
mean PDI score in our study (32.4) was comparable to
scores of patients with other pain syndromes.31 To our
knowledge, this study is the first study to link catas-
trophic thinking with QOL and perceived disability in a
sample of patients with PDN.
In order to understand the impact of PDN, it is
important to differentiate between perceived disability
and Physical Activity Decline. Disability refers to
problems in executing daily life tasks and activities.
Disability has been defined by the World Health
Organization as any restriction or lack of ability to
perform an activity in the manner or within the range
considered normal for a human being.32 Pain-related
disability questionnaires focus on the decrease in
capacity in the performance and altered performance
of regular activities in the daily life of patients with pain.
In contrast, Physical Activity Decline is defined as a
decrease in the level of physical activity as perceived by
the patient, which is relative to a person’s activity level
before the onset of the pain.33 This study shows that
patients who engage in catastrophic thinking experience
a greater decline in physical activity, while there was no
association between catastrophic thinking and the
estimated actual level of physical activity. This is in line
with previous studies in patients with low back
pain.33,34
PAD acted as a partial mediator in the associations
between catastrophic thinking and perceived disability,
and catastrophic thinking and QOL, respectively. This
means that catastrophic thinking is not solely a direct
predictor for perceived disability and QOL, but that this
association is also partially determined by the feeling of
loss in physical activity, which, on its turn, leads to
increased perceived disability (inability to perform an
activity) and lower QOL. Patients who catastrophize
about pain, probably also catastrophize about their loss
in physical activity, which further strengthens them in
feeling disabled and having a lower QOL. The identi-
fication of pain catastrophizing as a partial mediator is
valuable, as it suggests that an intervention that targets
pain catastrophizing will indirectly also improve per-
ceived disability and QOL.
In line with previous studies, pain intensity was a
significant contributor in the explanation of the associ-
ation of pain catastrophizing and perceived disability,
QOL and physical activity.8,35 Pain intensity showed no
contribution in the PAD, suggesting that the perception
of activity decline is not pain-induced but is probably
based on other mechanisms such as pain catastrophiz-
ing.
Insulin treatment is known to be highly burdensome
due to the method of administration (injections) and the
risks of hypoglycemia.36 Therefore, insulin treatment
can be considered a parameter for the severity of
diabetes. As expected, insulin treatment was associated
with low QOL and perceived disability. Interestingly,
insulin treatment showed a lower b-value in its associ-
ation with QOL and perceived disability as compared to
catastrophic thinking, suggesting that the a catastrophic
way of thinking is a greater predictor for the experienced
burden caused by PDN, than is insulin treatment. The
association of insulin treatment and perceived disability
was diminished after the addition of PAD to the model,
suggesting that insulin treatment seems to result in the
feeling of not being able to be as physically active as
before, which on its turn causes the perceived inability to
perform certain activities. Thus, insulin treatment was
not a direct predictor for perceived disability.
This study has several limitations. First, potential
participants for this study were derived from an already
existing database containing patients with type 2
diabetes. Only 183 of 2142 invited patients filled in
and returned the final questionnaire, resulting in a
potential self-selection bias. Secondly, diabetes-related
information is based on self-report. In order to over-
come this issue, we used multiple selected items (DNS
≥ 1 and DN4 ≥ 4) to identify eligible subjects according
to our inclusion criteria. In future studies, PDN should
be diagnosed by performing a clinical history and
peripheral neurological and vascular examination.
Thirdly, there was no information available on dia-
betes-related complications such as retinopathy or
nephropathy. Also scores on physical activity were
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solely based on self-report and there was no movement
registration. It should be noted, however, that informa-
tion on physical activities in the past can only be
obtained based on self-report. Future prospective studies
using objective physical measurements are advised, to
avoid the influence of a patients’ perception or interpre-
tation. For example, accelerometry could be a useful
addition to the PARS questionnaire. Lastly, this study
has a cross-sectional design in which the dependent and
independent variables are simultaneously assessed. For
this reason, results cannot provide information on a
causal relationship or a chronological order of the
relationship between pain catastrophizing and the out-
come variables.
Most current treatment modalities in PDN are one-
dimensional; they solely focus on the disease and/or pain
itself and rehabilitation interventions mainly improve
physical fitness. This study shows that it is important not
only to objectify the daily activity level of a patient with
PDN, but also to focus on the perceived change in a
patients’ activity level. This knowledge can have great
implications for the management of patients with PDN,
as treatment modalities that focus on pain or physical
activity alone most likely will not suffice.
In conclusion, neuropathic pain is a complex and
multidimensional condition, which often has a major
negative impact on daily life, both physically and
mentally. The present study illustrates that patients
with PDN who engage in catastrophic thinking experi-
ence a loss in physical activity, increased perceived
disability, and lesser QOL. Based on our results, we
stress the importance of integration of psychological
aspects such as pain catastrophizing in the treatment of
PDN.
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